Certara Services Archives

Blog

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…

CertaraMay 23, 2025

Live Events

Certainty China 2025

CertaraMay 22, 2025

Press Release

Certara Reports First Quarter 2025 Financial Results

RADNOR, PA— May 5, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraMay 5, 2025

Press Coverage

Rare disease drug development: challenges, support and hopes for the future

Explore rare disease drug development challenges, biosimulation solutions, and IRDiRC's significant role in transforming the…

CertaraApril 29, 2025

On-Demand Webinar

RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions

Senior Director, Regulatory Operations and Clinical Disclosure, Certara A seasoned pharmaceutical industry veteran, Evans Richardson…

CertaraApril 24, 2025

Announcement

Certara Announces Second Annual Certainty U.S. Event

Certara’s premier client conference explores how in-silico methods and biosimulation at scale derisk every stage…

CertaraApril 22, 2025

Blog

Using cost-effectiveness models for smarter drug development and healthcare decisions

April 14, 2025 Editor’s note: This is the second in a series of four articles…

CertaraApril 14, 2025

Press Coverage

FDA to phase out animal testing with AI and lab-based models

FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…

CertaraApril 11, 2025

Case Study

Delivering DSUR Excellence for Multinational Biopharma

A global leader in immuno-oncology approached us for support with over 50 simple to complex…

CertaraApril 11, 2025

Press Coverage

FDA plans to phase out animal testing requirements

Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…

CertaraApril 10, 2025

Certara Services

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Certainty China 2025

Certara Reports First Quarter 2025 Financial Results

Rare disease drug development: challenges, support and hopes for the future

RAPS Sponsored Webcast: Regulatory Writing and Operations to Accelerate Submissions

Certara Announces Second Annual Certainty U.S. Event

Using cost-effectiveness models for smarter drug development and healthcare decisions

FDA to phase out animal testing with AI and lab-based models

Delivering DSUR Excellence for Multinational Biopharma

FDA plans to phase out animal testing requirements

Newsletter sign up

Quick links

Solutions

Contact